Skip to content
★ Sign in to follow
Zepp Health Corp logo

Zepp Health Corp Stock: price and insider trades · United States

US·Mcap US$42.8MTechnology

Zepp Health Corp: what insiders have been doing

Zepp Health Corp belongs to the Technology sector. Filings by its managers are published through SEC (Form 4). From 22 October 2025 to 22 October 2026, the disclosure feed for Zepp Health Corp logged 7 filings by 5 insiders.

All open-market trades in the period are sales: 3 sales worth €77k, by 2 insiders, with no purchase on record. Deng Cheng filed the largest sale, €40k, on 29 June 2026.

With 7 filings in twelve months, the company is quieter than the median of 41 filings across the 2,023 companies we follow on the same exchange. Since 2026, the database holds no purchases and 3 sales by insiders of the company. On the fundamentals side, the SEC filing (20-F) for the period ending 31 December 2025 lists revenue at 258.9 m USD and net income at -40.1 m USD.

Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.

For comparison within the same sector, see the insider buying recorded at Hanza AB. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€76,786
3 ops. · all time

Who traded when

BuySale
Pengtao Yu2 sales
Cheng Deng1 sale

Analyst consensus: bullish or bearish?

Analysts rate Zepp Health Corp Strong Buy (bullish), based on 1 analysts. Average price target: US$43.86.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 25,764 of 26,911 companies
14.4
score / 100
Value
2
Quality
27
FCF yld-80%
Earn yld-121%
EV/EBITDA·
ROE-21%
Gross mgn38%
Net mgn-15%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$2.92
Analyst consensus
1 analysts
Strong buy
US$43.86Target US$43.86(+1402%)US$43.86
Income statement
RevenueUS$258.9M
Gross profitUS$99.2M38% margin
EBITDA-US$25.2M-10% margin
Net income-US$40.1M-15.8% margin
Valuation
PER (forward)-73.0x
P/Book0.2x
Beta1.81
Balance sheet & cash
Market capUS$42.8M
Total debtUS$229M
Free Cash Flow-US$26.5M
Debt / Equity73%
Profitability & ownership
ROE-21.2%
ROA-3.9%
% insiders22.2%
% institutions33.7%
Last declaration on 25 September 2026
Declarations7 total
  • ▼
    Chief Industrial DesignerExecutives
    24,724 USD21SEC
    5,749 shares@ US$4.30050.055% mcap19.2% of flowAmerican depositary sharesSEC:0001104659-26-110593:0
  • ▼
    Chief Industrial DesignerExecutives
    17,387 USD19SEC
    4,251 shares@ US$4.090.039% mcap13.6% of flowAmerican depositary sharesSEC:0001104659-26-110593:1
  • ●
    OfficerExecutives
    86,600 USD29Source
    20,000 shares@ US$4.330.19% mcap67.2% of flowADR(each representing 16 Class A ordinary shares)SEC144:0001738396-26-000014
  • ◇
    Chief Technology OfficerExecutives
    0SEC
    520,000 sharesClass A ordinary sharesSEC:0001104659-26-079107:0
  • ▼
    Chief Financial OfficerExecutives
    45,344 USD24SEC
    9,836 shares@ US$4.6148.8% of flowAmerican depositary sharesSEC:0001104659-26-078469:1
  • ◇
    Chief Financial OfficerExecutives
    0SEC
    22,875 sharesAmerican depositary sharesSEC:0001104659-26-078469:0
  • ●
    OfficerExecutives
    47,606 USD19Source
    9,836 shares@ US$4.840.061% mcap100.0% of flowADR(each representing 16 Class A ordinary shares)SEC144:0001738396-26-000010

7 of 7 declarations

About Zepp Health Corp

Zepp Health Corp is a health technology company that provides products and services related to wellness and fitness. It is listed on NASDAQ under the ticker XNAS.